figshare
Browse
gnpl_a_881363_sm7703.docx (1.01 MB)

Synthesis of bufalin derivatives with inhibitory activity against prostate cancer cells

Download (0 kB)
Version 3 2014-05-16, 14:23
Version 2 2014-05-16, 14:23
Version 1 2014-05-16, 14:23
journal contribution
posted on 2014-05-16, 14:23 authored by Xiao-Feng Yuan, Hai-Yan Tian, Juan Li, Lu Jin, Shu-Tai Jiang, Ken Wing-Keung Liu, Cheng Luo, David A. Middleton, Mikael Esmann, Wen-Cai Ye, Ren-Wang Jiang

Bufalin possesses a strong anti-cancer effect, but the cardiac toxicity targeting the Na+, K+-ATPase limits its application. Here, two bufalin derivatives, bufadienolactam (1) and secobufalinamide (2), were synthesised by treating bufalin with ammonium acetate in dimethylformamide solution. Their structures were elucidated by extensive spectroscopic methods. The structure of compound 2 was further confirmed by single-crystal X-ray diffraction analysis. Compounds 1 and 2 expressed strong inhibitory activities against androgen-dependent prostate cancer cells (IC50 values about 10 μM), but only weak inhibition on Na+, K+-ATPase (Ki about 70 μM), indicating that they might be potential anti-prostate cancer agents without severe cardiac toxicity.

History

Usage metrics

    Natural Product Research

    Categories

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC